Volume 20 Number 11
30 November 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 11, 30 November

Chang KT, Lin YY, Lin YY, Lin YL, Cheng H, Chang Y, Huang MC.
In Vivo Real-Time Discrimination Among Glioma, Infiltration Zone, and Normal Brain Tissue via Autofluorescence Technology.
World Neurosurg. 2018 Nov 1, 2019;122:e773-e782. doi: 10.1016/j.wneu.2018.10.144. PMID: 30391621. Laboratory investigation. ˍ

Porter AB, Sio TT, Nelson KD, Raghunathan A, Bendok BR, Mrugala MM.
Disseminated High-grade Glioma in a Long-term Survivor of Medulloblastoma: Implications and Management of Radiation-induced Malignancies.
Neurologist. 2018 Nov 1, 2018;23(6):191-193. doi: 10.1097/NRL.0000000000000199. PMID: 30379742. Case report. ˍ

Barkhoudarian G, Chowdhary S, Blondin N, Kesari S.
ACTR-26. A feasibility study of the Nativis Voyager® system in patients with newly diagnosed glioblastoma (GBM).
Neuro-Oncology, 2018 Nov 5, 2018;20(suppl_6):vi16–vi17. doi: 10.1093/neuonc/noy148.059. PMID: 30544353. Observational study. ˍ

Doyle SP, Gurbani SS, Ross AS, Rosen H, Barrett CD, Olson JJ, Shim H, Shu HK, Sengupta S.
The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma.
Oxf Med Case Reports. 2018 Nov 5, 2018;2018(12):omy095. doi: 10.1093/omcr/omy095. PMID: 30410775. Case report. ˍ

Zheng X, Liao Y, Wang J, Hu S, Rudramurthy GR, Swamy MK, Rohit KC, Wang Y.
The Antineuroinflammatory Effect of Simvastatin on Lipopolysaccharide Activated Microglial Cells.
Evid Based Complement Alternat Med. 2018 Nov 7, 2018;2018:9691085. doi: 10.1155/2018/9691085. PMID: 30524484. Laboratory investigation. ˍ

Corbetta C, Di Ianni N, Bruzzone MG, Patanè M, Pollo B, Cantini G, Cominelli M, Zucca I, Pisati F, Poliani PL, Finocchiaro G, Pellegatta S.
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.
Int J Cancer. 2018 Nov 12, 2019;144(10):2539-2554. doi: 10.1002/ijc.31985. PMID: 30418668. Laboratory investigation. ˍ

Post CCB, Kramer MCA, Smid EJ, van der Weide HL, Kleynen CE, Heesters MAAM, Verhoeff JJC.
Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.
Radiother Oncol. 2018 Nov 13, 2019;130:156-163. doi: 10.1016/j.radonc.2018.10.034. PMID: 30446315. Observational study. ˍ

Hwang K, Lee KS, Choe G, Cho BG, Kim CY.
Secondary glioblastoma after treatment of intracranial germinoma - would radiation-only therapy still be safe? Case report.
BMC Cancer. 2018 Nov 16, 2018;18(1):1119. doi: 10.1186/s12885-018-5073-3. PMID: 30445947. Case report. ˍ


Spiteri I, Caravagna G, Cresswell GD, Vatsiou A, Nichol D, Acar A, Ermini L, Chkhaidze K, Werner B, Mair R, Brognaro E, Verhaak RGW, Sanguinetti G, Piccirillo SGM, Watts C, Sottoriva A.
Evolutionary dynamics of residual disease in human glioblastoma.
Ann Oncol. 2018 Nov 19,
2019;30(3):456-463. doi: 10.1093/annonc/mdy506. PMID: 30452544. Laboratory investigation. ˍ


Murchison SC, Wiksyk B, Gossman S, Jensen B, Sayers D, Lesperance M, Truong PT, Alexander A.
Subventricular Zone Radiation Dose and Outcome for Glioblastoma Treated Between 2006 and 2012.
Cureus. 2018 Nov 21, 2018;10(11):e3618. doi: 10.7759/cureus.3618. PMID: 30697499. Observational study. ˍ

Withrow DR, Berrington de Gonzalez A, Lam CJ, Warren KE, Shiels MS.
Trends in pediatric central nervous system tumor incidence in the United States, 1998-2013.
Cancer Epidemiol Biomarkers Prev. 2018 Nov 21, 2019;28(3):522-530. doi: 10.1158/1055-9965.EPI-18-0784. PMID: 30464022. Observational study. ˍ

Wolf A, Naylor K, Tam M, Habibi A, Novotny J, Liščák R, Martinez-Moreno N, Martinez-Alvarez R, Sisterson N, Golfinos JG, Silverman J, Kano H, Sheehan J, Lunsford LD, Kondziolka D.
Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study.
Lancet Oncol. 2018 Nov 22, 2019;20(1):159-164. doi: 10.1016/S1470-2045(18)30659-4. PMID: 30473468. Observational study. ˍ

Mohammadi AM, Sharma M, Beaumont TL, Juarez KO, Kemeny H, Dechant C, Seas A, Sarmey N, Lee BS, Jia X, Fecci PE, Baehring J, Moliterno J, Chiang VL, Ahluwalia MS, Kim AH, Barnett GH, Leuthardt EC.
Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients.
Neurosurgery. 2018 Nov 23, 2019;85(6):762-772. doi: 10.1093/neuros/nyy449. PMID: 30476325. Observational study. ˍ

Di Stefano AL, Berzero G, Ducray F, Eoli M, Pichiecchio A, Farina LM, Cuccarini V, Brunelli MC, Diamanti L, Condette Auliac S, Salmaggi A, Silvani A, Giometto B, Pace A, Vidiri A, Bourdain F, Bastianello S, Ceroni M, Marchioni E.
"Stroke-like" events after brain radiotherapy: a large series with long-term follow-up.
Eur J Neurol. 2018 Nov 24, 2019;26(4):639-650. doi: 10.1111/ene.13870. PMID: 30471162. Observational study. ˍ

Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ Jr, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP.
Phase 2 Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
Int J Radiat Oncol Biol Phys. 2018 Nov 26, 2019;103(4):878-886. doi: 10.1016/j.ijrobp.2018.11.008. PMID: 30496882. Interventional study. ˍ

Barboriak DP, Zhang Z, Desai P, Snyder BS, Safriel Y, McKinstry RC, Bokstein F, Sorensen G, Gilbert MR, Boxerman JL.
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.
Radiology. 2018 Nov 27, 2019;290(2):467-476. doi: 10.1148/radiol.2019181296. PMID: 30480488. Interventional study. ˍ

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
J Neurooncol. 2018 Nov 28, 2019;142(1):69-77. doi: 10.1007/s11060-018-03063-1. PMID: 30488294. Observational study. ˍ

Geevar T, Pai R, Chacko G, Malepathi K, Patel B, John J, Chacko AG, Balakrishnan R, John S.
Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
Neurol India. 2018 Nov 28, 2018;66(6):1726-1731. doi: 10.4103/0028-3886.246275. PMID: 30504574. Laboratory investigation. ˍ


Jhaveri J, Cheng E, Tian S, Buchwald Z, Chowdhary M, Liu Y, Gillespie TW, Olson JJ, Diaz AZ, Voloschin A, Eaton BR, Crocker IR, McDonald MW, Curran WJ, Patel KR.
Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
Front Oncol. 2018 Nov 28, 2018;8:440. doi: 10.3389/fonc.2018.00440. PMID: 30547008. Observational study. ˍ

Mathew BS, Kaliyath SB, Krishnan J, Bhasi S.
Impact of subventricular zone irradiation on outcome of patients with glioblastoma.
J Cancer Res Ther. 2018 Nov 28, 2018;14(6):1202-1206. doi: 10.4103/jcrt.JCRT_295_17. PMID: 30488830. Observational study. ˍ

van der Louw EJTM, Reddingius RE, Olieman JF, Neuteboom RF, Catsman-Berrevoets CE.
Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study.
Pediatr Blood Cancer. 2018 Nov 28, 2019:e27561→. doi: 10.1002/pbc.27561→. PMID: 30484948. Case report. ˍ

Stavrinou P, Kalyvas A, Grau S, Hamisch C, Galldiks N, Katsigiannis S, Kabbasch C, Timmer M, Goldbrunner R, Stranjalis G.
Survival effects of a strategy favoring second-line multimodal treatment compared to supportive care in glioblastoma patients at first progression.
J Neurosurg. 2018 Nov 30, 2018;131(4):1136-1141→. doi: 10.3171/2018.7.JNS18228. PMID: 30544353. Observational study. ˍ